Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy C Okell

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Infection and Immunity|June 23, 2010
Neutralization of malaria glycosylphosphatidylinositol in vitro by serum IgG from malaria-exposed individualsJ Brian de Souza, Manohursingh Runglall, Patrick H Corran, et al.
Plos One|June 2, 2011
The potential contribution of mass treatment to the control of Plasmodium falciparum malariaLucy C Okell, Jamie T Griffin, Immo Kleinschmidt, et al.
BMJ Global Health|November 7, 2018
Emerging implications of policies on malaria treatment: genetic changes in the <i>Pfmdr-1</i> gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in AfricaLucy C Okell, Lisa Malene Reiter, Lene Sandø Ebbe, et al.
BMC Medicine|January 13, 2022
Modelling upper respiratory viral load dynamics of SARS-CoV-2Joseph D Challenger, Cher Y Foo, Yue Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East AsiaCecile P G Meier-Scherling, Oliver J Watson, Victor Asua, et al.
Nature Communications|November 27, 2014
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisLucy C Okell, Matthew Cairns, Jamie T Griffin, et al.
The Lancet. Microbe|March 20, 2025
Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling studyCecile P G Meier-Scherling, Oliver J Watson, Victor Asua, et al.
Plos Medicine|August 17, 2010
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategiesJamie T Griffin, T Deirdre Hollingsworth, Lucy C Okell, et al.
BMJ Global Health|May 19, 2022
Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and NigeriaMonica Anna de Cola, Benoît Sawadogo, Sol Richardson, et al.
Malaria Journal|August 19, 2015
Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan AfricaMatthew E Cairns, Patrick G T Walker, Lucy C Okell, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Infection and Immunity|June 23, 2010
Neutralization of malaria glycosylphosphatidylinositol in vitro by serum IgG from malaria-exposed individualsJ Brian de Souza, Manohursingh Runglall, Patrick H Corran, et al.
Plos One|June 2, 2011
The potential contribution of mass treatment to the control of Plasmodium falciparum malariaLucy C Okell, Jamie T Griffin, Immo Kleinschmidt, et al.
BMJ Global Health|November 7, 2018
Emerging implications of policies on malaria treatment: genetic changes in the <i>Pfmdr-1</i> gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in AfricaLucy C Okell, Lisa Malene Reiter, Lene Sandø Ebbe, et al.
BMC Medicine|January 13, 2022
Modelling upper respiratory viral load dynamics of SARS-CoV-2Joseph D Challenger, Cher Y Foo, Yue Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East AsiaCecile P G Meier-Scherling, Oliver J Watson, Victor Asua, et al.
Nature Communications|November 27, 2014
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisLucy C Okell, Matthew Cairns, Jamie T Griffin, et al.
The Lancet. Microbe|March 20, 2025
Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling studyCecile P G Meier-Scherling, Oliver J Watson, Victor Asua, et al.
Plos Medicine|August 17, 2010
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategiesJamie T Griffin, T Deirdre Hollingsworth, Lucy C Okell, et al.
BMJ Global Health|May 19, 2022
Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and NigeriaMonica Anna de Cola, Benoît Sawadogo, Sol Richardson, et al.
Malaria Journal|August 19, 2015
Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan AfricaMatthew E Cairns, Patrick G T Walker, Lucy C Okell, et al.
Pageof 6